James A Davis (James Davis)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 47

Top Topics

Multiple Myeloma

Systematic Review

Epstein Barr Virus

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

Expert review of hematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology 204 (4) (2024)
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology 204 (4) (2024)
Nico Gagelmann, Danai Dima, Maximilian Merz, Hamza Hashmi, Nausheen Ahmed, Natalia Tovar, Marta Garrote, Friedrich Stölzel, Kristin Rathje, Luise Fischer, Patrick Born, Lisa Schäfer, Anca-Maria Albici, Natalie Schub, Shlomit Kfir-Erenfeld, Miri Assayag, Nathalie Asherie, Gerald Georg Wulf, Soraya Kharboutli, Fabian Müller, Leyla Shune, James A Davis, Faiz Anwar, Vladan Vucinic, Uwe Platzbecker, Francis Ayuk, Nicolaus Kröger, Jack Khouri, Carmelo Gurnari, Joseph P McGuirk, Polina Stepensky, Al-Ola Abdallah, Carlos Fernández de Larrea
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Nico Gagelmann, Danai Dima, Maximilian Merz, Hamza Hashmi, Nausheen Ahmed, Natalia Tovar, Marta Garrote, Friedrich Stölzel, Kristin Rathje, Luise Fischer, Patrick Born, Lisa Schäfer, Anca-Maria Albici, Natalie Schub, Shlomit Kfir-Erenfeld, Miri Assayag, Nathalie Asherie, Gerald Georg Wulf, Soraya Kharboutli, Fabian Müller, Leyla Shune, James A Davis, Faiz Anwar, Vladan Vucinic, Uwe Platzbecker, Francis Ayuk, Nicolaus Kröger, Jack Khouri, Carmelo Gurnari, Joseph P McGuirk, Polina Stepensky, Al-Ola Abdallah, Carlos Fernández de Larrea
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kevin C Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J Gaffney, Kimberly Green, Brian T Hess, Hamza Hashmi
"Fast but not so furious" : A condensed step-up dosing schedule of teclistamab for relapsed/refractory multiple myeloma. EJHaem 5 (4) (2024)
Nico Gagelmann, Danai Dima, Maximilian Merz, Hamza Hashmi, Nausheen Ahmed, Natalia Tovar, Marta Garrote, Friedrich Stölzel, Kristin Rathje, Luise Fischer, Patrick Born, Lisa Schäfer, Anca-Maria Albici, Natalie Schub, Shlomit Kfir-Erenfeld, Miri Assayag, Nathalie Asherie, Gerald Georg Wulf, Soraya Kharboutli, Fabian Müller, Leyla Shune, James A Davis, Faiz Anwar, Vladan Vucinic, Uwe Platzbecker, Francis Ayuk, Nicolaus Kröger, Jack Khouri, Carmelo Gurnari, Joseph P McGuirk, Polina Stepensky, Al-Ola Abdallah, Carlos Fernández de Larrea
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nico Gagelmann, Danai Dima, Maximilian Merz, Hamza Hashmi, Nausheen Ahmed, Natalia Tovar, Marta Garrote, Friedrich Stölzel, Kristin Rathje, Luise Fischer, Patrick Born, Lisa Schäfer, Anca-Maria Albici, Natalie Schub, Shlomit Kfir-Erenfeld, Miri Assayag, Nathalie Asherie, Gerald Georg Wulf, Soraya Kharboutli, Fabian Müller, Leyla Shune, James A Davis, Faiz Anwar, Vladan Vucinic, Uwe Platzbecker, Francis Ayuk, Nicolaus Kröger, Jack Khouri, Carmelo Gurnari, Joseph P McGuirk, Polina Stepensky, Al-Ola Abdallah, Carlos Fernández de Larrea
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology 204 (4) (2024)
Danai Dima, Al-Ola Abdallah, James A Davis, Hussein Awada, Utkarsh Goel, Aliya Rashid, Shaun DeJarnette, Faiz Anwar, Leyla Shune, Shahzad Raza, Zahra Mahmoudjafari, Louis Williams, Beth Faiman, Joseph P McGuirk, Craig S Sauter, Nausheen Ahmed, Jack Khouri, Hamza Hashmi
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy. Blood cancer journal 14 (1) (2024)
Nico Gagelmann, Danai Dima, Maximilian Merz, Hamza Hashmi, Nausheen Ahmed, Natalia Tovar, Marta Garrote, Friedrich Stölzel, Kristin Rathje, Luise Fischer, Patrick Born, Lisa Schäfer, Anca-Maria Albici, Natalie Schub, Shlomit Kfir-Erenfeld, Miri Assayag, Nathalie Asherie, Gerald Georg Wulf, Soraya Kharboutli, Fabian Müller, Leyla Shune, James A Davis, Faiz Anwar, Vladan Vucinic, Uwe Platzbecker, Francis Ayuk, Nicolaus Kröger, Jack Khouri, Carmelo Gurnari, Joseph P McGuirk, Polina Stepensky, Al-Ola Abdallah, Carlos Fernández de Larrea
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Donald C Moore, Katelynn Granger, Hailey Hill, Allison Karabinos, James A Davis
Elranatamab vs. teclistamab: battle of the BCMA bispecifics in relapsed/refractory multiple myeloma. Expert review of hematology (2024)
Kevin C Graf, James A Davis, Alyssa Cendagorta, Katelynn Granger, Kelly J Gaffney, Kimberly Green, Brian T Hess, Hamza Hashmi
"Fast but not so furious" : A condensed step-up dosing schedule of teclistamab for relapsed/refractory multiple myeloma. EJHaem 5 (4) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Donald C Moore, Katelynn Granger, Hailey Hill, Allison Karabinos, James A Davis
Elranatamab vs. teclistamab: battle of the BCMA bispecifics in relapsed/refractory multiple myeloma. Expert review of hematology (2024)
Danai Dima, Aliya Rashid, James A Davis, Leyla Shune, Al-Ola Abdallah, Hong Li, Shaun DeJarnette, Jack Khouri, Louis Williams, Hamza Hashmi, Shahzad Raza, Joseph McGuirk, Faiz Anwer, Nausheen Ahmed
Efficacy and safety of idecabtagene vicleucel in patients with relapsed-refractory multiple myeloma not meeting the KarMMa-1 trial eligibility criteria: A real-world multicentre study. British journal of haematology (2024)
Danai Dima, Al-Ola Abdallah, James A Davis, Hussein Awada, Utkarsh Goel, Aliya Rashid, Shaun DeJarnette, Faiz Anwar, Leyla Shune, Shahzad Raza, Zahra Mahmoudjafari, Louis Williams, Beth Faiman, Joseph P McGuirk, Craig S Sauter, Nausheen Ahmed, Jack Khouri, Hamza Hashmi
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy. Blood cancer journal 14 (1) (2024)
James A Davis, Mary McGann, Jessica Marini, Hamza Hashmi
How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy. Expert review of anticancer therapy 24 (6) (2024)
Donald C Moore, Katelynn Granger, Hailey Hill, Allison Karabinos, James A Davis
Elranatamab vs. teclistamab: battle of the BCMA bispecifics in relapsed/refractory multiple myeloma. Expert review of hematology 17 (6) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Danai Dima, Al-Ola Abdallah, James A Davis, Hussein Awada, Utkarsh Goel, Aliya Rashid, Shaun DeJarnette, Faiz Anwar, Leyla Shune, Shahzad Raza, Zahra Mahmoudjafari, Louis Williams, Beth Faiman, Joseph P McGuirk, Craig S Sauter, Nausheen Ahmed, Jack Khouri, Hamza Hashmi
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy. Blood cancer journal 14 (1) (2024)
Aimaz Afrough, Hamza Hashmi, Doris K Hansen, Surbhi Sidana, Chul Ahn, Lauren C Peres, Danai Dima, Ciara L Freeman, Omar Castaneda Puglianini, Mehmet H Kocoglu, Shebli Atrash, Peter M Voorhees, Leyla Shune, Joseph P McGuirk, Gary Simmons, Douglas W Sborov, James A Davis, Gurbakhash N M N Kaur, Aishwarya Sannareddy, Christopher J Ferreri, Mahmoud R Gaballa, Scott Goldsmith, Omar Nadeem, Shonali Midha, Charlotte B Wagner, Frederick L Locke, Krina K Patel, Jack Khouri, Larry D Anderson, Yi Lin
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium. Blood cancer journal 14 (1) (2024)
Danai Dima, Al-Ola Abdallah, James A Davis, Hussein Awada, Utkarsh Goel, Aliya Rashid, Shaun DeJarnette, Faiz Anwar, Leyla Shune, Shahzad Raza, Zahra Mahmoudjafari, Louis Williams, Beth Faiman, Joseph P McGuirk, Craig S Sauter, Nausheen Ahmed, Jack Khouri, Hamza Hashmi
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy. Blood cancer journal 14 (1) (2024)
Kelly J Gaffney, Jonathan K Bakos, Arash Velayati, James A Davis, Aswani Thurlapati, Erin Weeda, Andy Maldonado, Katelynn Granger, Coleen Butcher, Taylor Herrington, Deidra Smith, Kimberly Green, Brian T Hess, Hamza Hashmi
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
James A Davis, Mary McGann, Jessica Marini, Hamza Hashmi
How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy. Expert review of anticancer therapy (2024)
James A Davis, Mary McGann, Jessica Marini, Hamza Hashmi
How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy. Expert review of anticancer therapy 24 (6) (2024)
Nico Gagelmann, Danai Dima, Maximilian Merz, Hamza Hashmi, Nausheen Ahmed, Natalia Tovar, Marta Garrote, Friedrich Stölzel, Kristin Rathje, Luise Fischer, Patrick Born, Lisa Schäfer, Anca-Maria Albici, Natalie Schub, Shlomit Kfir-Erenfeld, Miri Assayag, Nathalie Asherie, Gerald Georg Wulf, Soraya Kharboutli, Fabian Müller, Leyla Shune, James A Davis, Faiz Anwar, Vladan Vucinic, Uwe Platzbecker, Francis Ayuk, Nicolaus Kröger, Jack Khouri, Carmelo Gurnari, Joseph P McGuirk, Polina Stepensky, Al-Ola Abdallah, Carlos Fernández de Larrea
Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Mary McGann, Arash Velayati, Kiera Roubal, Katelynn Granger, James A Davis, Kelly J Gaffney, Erin Weeda, Hamza Hashmi
Early cytopenias and infections following chimeric antigen receptor T-Cell therapy for hematologic malignancies. Leukemia & lymphoma (2023)
Hamza Hashmi, James A Davis, Al-Ola Abdallah
'A Stitch in Time Saves Nine': Early stem cell transplant continues to improve outcomes in patients with newly diagnosed multiple myeloma. Expert review of hematology (2023)
Katelynn Granger, Kelly J Gaffney, James A Davis
Newly approved and forthcoming T-cell-redirecting bispecific antibodies for the treatment of relapsed/refractory multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
James A Davis, Aswani Thurlapati, Erin Weeda, Kelly J Gaffney, Deidra Smith, Andy Maldonado, Katelynn Granger, Kristy E Martin, Yolanda M Williams, Taylor Herrington, Arash Velayati, Jonathan K Bakos, Kimberly Green, Hamza Hashmi
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma. Annals of hematology (2023)
Kelly J Gaffney, James A Davis, Mary McGann, Kathy Edwards, Zaheer Ahmed, Colleen Butcher, Brian Greenwell, Brian T Hess, Hamza Hashmi
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk, Douglas W Sborov, Charlotte B Wagner, M Hakan Kocoglu, Aaron Rapoport, Shebli Atrash, Peter M Voorhees, Jack Khouri, Danai Dima, Aimaz Afrough, Gurbakhash Kaur, Larry D Anderson, Gary Simmons, James A Davis, Nilesh Kalariya, Lauren C Peres, Yi Lin, Murali Janakiram, Omar Nadeem, Melissa Alsina, Frederick L Locke, Surbhi Sidana, Doris K Hansen, Krina K Patel, Omar Castaneda Puglianini
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy. Blood cancer journal 13 (1) (2023)
James A Davis, Katelynn Granger, Alex Sakowski, Sara Goodwin, Amanda Herbst, Deidra Smith, Lindsey Hendrickson, Victoria R Nachar
Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma. Expert review of hematology (2023)
Lauren C Peres, Laura B Oswald, Christen M Dillard, Gabriel De Avila, Taiga Nishihori, Brandon J Blue, Ciara Louise Freeman, Frederick L Locke, Melissa Alsina, Omar Castaneda Puglianini, Leyla Shune, Douglas W Sborov, Charlotte B Wagner, Danai Dima, Hamza Hashmi, James A Davis, Mehmet Hakan Kocoglu, Ashraf Z Badros, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher J Ferreri, Larry D Anderson, Aimaz Afrough, Gurbakhash N M N Kaur, Yi Lin, Lawrence Liu, Omar Nadeem, Peter M Voorhees, Jack Khouri, Joseph P McGuirk, Surbhi Sidana, Doris K Hansen, Krina K Patel
Racial and ethnic differences in clinical outcomes among multiple myeloma patients treated with CAR T-cell therapy. Blood advances (2023)
Aswani Thurlapati, Mary McGann, James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J Gaffney, Alyssa Cendagorta, Amanda Herbst, Lindsey Hendrickson, Brian T Hess, Hamza Hashmi
Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients. Journal of medical virology 95 (8) (2023)
James A Davis, David A Rizzieri, Andrew A Lane, Justin Taylor, Muhammad Salman Faisal, Sumithira Vasu, Deborah Soong, Hong Li, Amanda Herbst, I Brian Greenwell
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Leukemia & lymphoma 63 (11) (2022)
Mary McGann, Kelly J Gaffney, James A Davis, Deidra Smith, Hamza Hashmi
Organ toxicities associated with chimeric antigen receptor T-cell therapy. Leukemia & lymphoma (2022)
James A Davis, Abigail Shockley, Ashley E Glode
Newly approved anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory diffuse large B-cell lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (3) (2022)
Hamza Hashmi, Abigail Shockley, James A Davis
'Save the day with a Stem Cell Rescue': Use of autologous hematopoietic stem cell boost for hematopoietic recovery after CAR T cell therapy. Bone marrow transplantation 57 (3) (2022)
James A Davis, Anastasia Graham, Lindsey Hendrickson, Brian Hess, Kelly Gaffney
Incidence of Pneumocystis jirovecii pneumonia (PJP) in patients receiving BTK inhibitors who did not receive PJP prophylaxis. Leukemia & lymphoma 63 (8) (2022)
Abigail Shockley, James A Davis, Kelly J Gaffney, Deidra Smith, Erin Weeda, Hamza Hashmi
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (7) (2022)
James A Davis, Hamza Hashmi
ANDROMEDA: Dara-VCd for newly diagnosed AL amyloidosis: the next galaxy or a new standard of care? Expert opinion on biological therapy 22 (4) (2022)
James A Davis, Mary McGann, Abigail Shockley, Hamza Hashmi
Idecabtagene vicleucel versus ciltacabtagene autoleucel: a Sophie's choice for patients with relapsed refractory multiple myeloma. Expert review of hematology 15 (6) (2022)
Adeel Masood, Ahsan Wahab, Qamar Iqbal, James A Davis, Hamid Ehsan, Hamza Hashmi
Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature. Bone marrow transplantation 57 (6) (2022)
James A Davis, Jagoda Misniakiewicz, Lindsey Hendrickson, Mary McGann, Amanda Herbst, Brian T Hess
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy. Annals of hematology (2022)
James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J Gaffney, Mary McGann, Alyssa M Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T Hess
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies. Blood (2022)
James A Davis, Abigail Shockley, Hamza Hashmi
The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (4) (2022)